TALLAHASSEE, Fla., Sept. 24 -- Florida State University issued the following news release:
People taking popular GLP-1 medications such as Ozempic, Wegovy and Zepbound may face stigma from those closest to them, according to a new study by a Florida State University professor.
Braidyn Lazenby, an assistant professor at FSU's College of Communication & Information, led the study "'They Call Us Cheaters:" Exploring Stigma Management Communication Strategies During GLP-1 Medication Use.'" The findings were published last week in Health Communication.
Lazenby and her fellow researchers conducted open-ended, one-on-one interviews with 34 adults who were taking GLP-1 medications for weight management, metabolic disorders and other health condi...